Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- CheckyesterdayChange DetectedDifference0.2%
- Check8 days agoChange DetectedThe page has updated its location details to specify 'Sachsen Locations' and has changed the date references, removing some past dates and adding new ones. Additionally, the revision number has been updated from v2.15.0 to v2.15.2.SummaryDifference1%
- Check16 days agoChange DetectedDifference0.3%
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed trial information regarding the efficacy and safety of tisagenlecleucel for treating aggressive B-cell Non-Hodgkin Lymphoma, while adding a new revision number and a trial identifier.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.SummaryDifference0.4%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of February 28, 2025.SummaryDifference0.5%
Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.